Glomerular Filtration Rate in Neonates

Nephrology and Fluid/Electrolyte Physiology: Neonatology Questions and Controversies Expert Consult

Volumn , Issue , 2012, Pages 117-135

  Guignard, Jean Pierre ^a   Gouyon, Jean Bernard ^b  

^a University of Lausanne Medical Center   (Switzerland)

^b GHSR Reunion Island   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85133574933     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2658-9.00008-X     Document Type: Chapter

References (98)

1. Guignard JP, John EG Renal function in the tiny, premature infant. Clin Perinatol 1986, 13:377.
2. Turner AJ, Brown RD, Carlström A, et al. Mechanisms of neonatal increase in glomerular filtration rate. Am J Physiol Regul Integr Comp Physiol 2008, 295:916.
3. Arendshorst WJ, Brännström K, Ruan X Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 1999, 10:S149.
4. Guignard JP, Gouyon JB, John E Vasoactive factors in the immature kidney. Pediatr Nephrol 1991, 5:443.
5. Morris JL, Rosen DA, Rosen KR Nonsteroidal anti-inflammatory agents in neonates. Paediatr Drug 2003, 5:385.
6. Hao CM, Breyer MD Physiological regulation of prostaglandins in the kidney. Ann Rev Physiol 2008, 70:357.
7. Gomez RA, Pupilli C, Everett AD Molecular and cellular aspects of renin during kidney ontogeny. Pediatr Nephrol 1991, 5:80.
8. Madsden K, Marcussen N, Pedersen M, et al. Angiotensin II promotes development of the renal microcirculation through its AT1 receptors. J Am Soc Nephrol 2010, 21:448.
9. Gubler MC, Antignac C Renin-angiotensin system in kidney development: renal tubular dysgenesis. Kidney Int 2010, 77:400.
10. Norwood VF, Craig MR, Harris JM, et al. Differential expression of angiotensin II receptors during early renal morphogenesis. Am J Physiol 1997, 272:R662.
11. Tufro-McReddie A, Harrison JK, Everett AD, et al. Ontogeny of type 1 angiotensin II receptor gene expression in the rat. J Clin Invest 1993, 91:530.
12. Tufro-McReddie A, Romano LM, Harris JM, et al. Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 1995, 269:F110.
13. Prévot A, Mosig D, Guignard JP The effects of losartan on renal function in the newborn rabbit. Pediatr Res 2002, 51:728.
14. Khan KN, Paulson SK, Verburg KM, et al. Pharmacology of cyclooxygenase-2 inhibition in the kidney. Kidney Int 2002, 61:1210.
15. Kömoff M, Wang JL, Cheng HF, et al. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 2000, 57:14.
16. Norwood VF, Morham SG, Smithies O Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null-mice. Kidney Int 2000, 58:2291.
17. Coulthard MG, Ruddock V Validation of inulin as a marker for glomerular filtration in preterm babies. Kidney Int 1983, 23:407.
18. Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006, 52:169.
19. Boer DP, de Rijke YB, Hop WC, et al. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol 2010, 25:2010.
20. Stokes P, O'Connor G Development of a liquid chromatography-mass spectrometry method for high-accuracy determination of creatinine in serum. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 794:125.
21. Matos P, Duarte-Silva M, Drukker A, Guignard JP Creatinine reabsorption by the newborn rabbit kidney. Pediatr Res 1998, 44:639.
22. Guignard JP, Drukker A Why do newborn infants have a high plasma creatinine?. Pediatrics 1999, 103:e49.
23. Lindblad HG, Berg HB Comparative evaluation of iohexol and inulin clearance for glomerular filtration rate determinations. Acta Paediatr 1994, 83:418.
24. Berg UB, Bäck R, Celsi G, et al. Comparison of plasma clearance of iohexol and urinary clearance of inuline for measurement of GFR in children. Am J Kidney Dis 2011, 57:55.
25. Odlind B, Hallgren R, Sohtell M, et al. Is 1251 iothalamate an ideal marker for glomerular filtration?. Kidney Int 1985, 27:9.
26. Gallini F, Maggio L, Romagnoli C, et al. Progression of renal function in preterm neonates with gestational age ?32 weeks. Pediatr Nephrol 2000, 15:119.
27. Miall LS, Henderson MJ, Turner AJ, et al. Plasma creatinine rises dramatically in the first 48 hours of life in preterm infants. Pediatrics 1999, 6:104.
28. Bueva A, Guignard JP Renal function in preterm neonates. Pediatr Res 1994, 36:572.
29. Thayyil S, Sheik S, Kempley ST, et al. A gestation- and postnatal age- based reference chart for assessing renal function in extremely premature infants. J Perinatol 2008, 28:226.
30. Iacobelli S, Bonsante F, Ferdinus C, et al. Factors affecting postnatal changes in serum creatinine in preterm infants with gestational <32 weeks. J Perinatol 2009, 29:232.
31. Stonestreet BS, Bell EF, Oh W Validity of endogenous creatinine clearance in low birthweight infants. Pediatr Res 1979, 13:1002.
32. Coulthard MG, Hey EN, Ruddock V Creatinine and urea clearances compared to inulin clearance in preterm and mature babies. Early Hum Dev 1985, 11:11.
33. Vieux R, Hascoet JM, Merdariu D, et al. Glomerular filtration rate reference values in very premature infants. Pediatrics 2010, 125:e1186.
34. Cole BR, Giangiacomo J, Ingelfinger JR, et al. Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technique for determination of inulin and para-aminohippurate. N Engl J Med 1972, 287:1109.
35. vd Heijden AJ, Grose WF, Ambagtsheer JJ, et al. Glomerular filtration rate in the preterm infant: the relation to gestational and postnatal age. Eur J Pediatr 1988, 148:24.
36. Coulthard MG Comparison of methods of measuring renal function in preterm babies using inulin. J Pediatr 1983, 102:923.
37. Fawer CL, Torrado A, Guignard JP Maturation of renal function in full-term and premature neonates. Helv Paediatr Acta 1979, 34:11.
38. Counahan R, Chantler C, Ghazali S, et al. Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 1976, 51:875.
39. Schwartz GJ, Brion LP, Spitzer A The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987, 34:571.
40. Haenggi MH, Pelet J, Guignard JP Estimation of glomerular filtration rate by the formula GFR = K × T/Pc. Arch Pediatr 1999, 6:165.
41. Olafsson I The human cystatin C gene promotor: functional analysis and identification of heterogeneous mRNA. Scand J Clin Lab Invest 1995, 55:597.
42. Tenstad O, Roald AB, Grubb A Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996, 56:409.
43. Erlandsen EJ, Randers E, Kristensen JH Evaluation of the N Latex Cystatin C assay on the Dade Behring Nephelometer II system. Scand J Clin Lab Invest 1999, 59:1.
44. Finney H, Newman DJ, Thakkar H, et al. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 2000, 82:71.
45. Randers E, Krue S, Erlandsen EJ, et al. Reference interval for serum cystatin C in children. Clinical Chemistry 1999, 45:1856.
46. Stickle D, Cole B, Hock K, et al. Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem 1998, 44:1334.
47. Bökenkamp A, Domanetzki M, Zinck R, et al. Reference values for cystatin C serum concentrations in children. Pediatr Nephrol 1998, 12:125.
48. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004, 65:777.
49. Akbari A, Lepage N, Keely E, et al. Cystatin-C and beta trace protein as markers of renal function in pregnancy. BJOG 2005, 112:575.
50. Podraacka L, Feber J, Lepage N, et al. Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients. Pediatr Transplant 2005, 9:28.
51. Mendiluce A, Bustamante J, Martin D, et al. Cystatin C as a marker of renal function in kidney transplant patients. Transplant Proc 2005, 37:3844.
52. Bökenkamp A, van Wijk JAE, Lentze MJ, et al. Effects of corticosteroid therapy on serum cystatin C and beta 2-microglobulin concentrations. Clin Chem 2002, 48:1123.
53. Wulkan R, den Hollander J, Berghout A Cystatin C unsuited to use as a marker of kidney function in the intensive care unit. Crit Care 2005, 9:531.
54. Martini S, Prévot A, Mosig D, Guignard JP Glomerular filtration rate: measure creatinine and height rather than cystatin C!. Acta Paediatr 2003, 92:1052.
55. Cataldi L, Mussap M, Bertelli N, et al. Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 1999, 16:287.
56. Harmoinen A, Ylinen E, Ala-Houhala M, et al. Reference intervals for cystatin C in pre-and full-term infants and children. Pediatr Nephrol 2000, 15:105.
57. Armangil D, Yurka M, Canpolat FE, et al. Determination of reference values for plasma cystatin C and comparison with creatinine in premature infants. Pediatr Nephrol 2008, 23:2081.
58. Filler G, Bökenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR: history, indications, and future research. Clin Biochem 2005, 38:1.
59. Toth-Heynh P, Drukker A, Guignard JP The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 2000, 14:227.
60. Gouyon JB, Guignard JP Management of acute renal failure in newborns. Pediatr Nephrol 2000, 14:1037.
61. Choker G, Gouyon JB Diagnosis of acute renal failure in very preterm infants. Biol Neonate 2004, 86:212.
62. Cataldi L, Leone R, Moretti U, et al. Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Arch Dis Child Fetal Neonatal Ed 2005, 90:F514.
63. Gouyon JB, Guignard JP Theophylline prevents the hypoxemia-induced renal hemodynamic changes in rabbits. Kidney Int 1988, 33:1078.
64. Gouyon JB, Arnaud M, Guignard JP Renal effects of low-dose aminophylline and enprofylline in newborn rabbits. Life Sci 1988, 42:1271.
65. Abhyankar S, Salvi VS Indomethacin therapy in hydrammios. J Postgrad Med 2000, 46:176.
66. vd Heijden AJ, Provoost AP, Nauta J, et al. Renal function impairment in preterm neonates related to intrauterine indomethacin exposure. Pediatr Res 1988, 24:644.
67. Catterton Z, Sellers B, Gray B Inulin clearance in the premature infant receiving indomethacin. J Pedriatr 1980, 96:737.
68. Akima S, Kent A, Reynolds GJ, et al. Indomethacin and renal impairment in neonates. Pediatr Nephrol 2004, 19:490.
69. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000, 343:674.
70. Thomas RL, Parker GC, Van Overmeire B, et al. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005, 164:135.
71. Ohlsson A, Walia R, Schah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2003;2:CD003481.
72. Allegaert K, Cossey V, Langhendries JP, et al. Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. Biol Neonate 2004, 86:207.
73. Allegaert K, Vanhole C, de Hoon J, et al. Nonselective cyclo-oxygenase inhibitors and glomerular filtration rate in preterm neonates. Pediatr Nephrol 2005, 20:1557.
74. Guignard JP The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit. Semin Perinatol 2002, 26:398.
75. Chamaa NS, Mosig D, Drukker A, et al. The renal hemodynamic effects of ibuprofen in the newborn rabbit. Pediatr Res 2000, 48:600.
76. Prevot A, Mosig D, Martini S, et al. Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit. Pediatr Res 2004, 55:254.
77. Peruzzi L, Gianoglio B, Porcellini M, et al. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase type I selective inhibitor nimesulide as tocolytic. Lancet 1999, 354:9190.
78. Ali US, Khubchandani S, Andankar P, et al. Renal tubular dysgenesis associated with in utero exposure to nimesulide. Pediatr Nephrol 2006, 21:274.
79. Cunniff C, Jones KL, Phillipson J, et al. Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use. Am J Obstet Gynecol 1990, 162:187.
80. Guignard JP, Burgener F, Calame A Persistent anuria in a neonate: a side effect of captopril?. Int J Pediatr Nephrol 1981, 2:133.
81. Vendemmia M, Garcia-Méric P, Rizzoti A, et al. Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists. J Matern Fetal Neonatal Med 2005, 18:137.
82. Gersak K, Cvijic M, Cerar LK Angiotensin II receptor blockers in pregnancy: a report of five cases. Reprod Toxicol 2009, 28:109.
83. Guron G, Mölne J, Swerkersson S, et al. A 14-year-old girl with renal abnormalities after brief intrauterine exposure to enalapril during late gestation. Nephrol Dial Transplant 2006, 21:522.
84. Tack ED, Perlman JM Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 1988, 112:805.
85. Lynch SK, Lemley KV, Polak MJ The effect of dopamine on glomerular filtration rate in normotensive, oliguric premature neonates. Pediatr Nephrol 2003, 18:649.
86. Seri I, Abbasi S, Wood DC, et al. Regional hemodynamic effects of dopamine in the indomethacin-treated preterm infant. J Perinatol 2002, 22:300.
87. Prins I, Plötz FB Cuno SPM, et al. Low-dose dopamine in neonatal and pediatric intensive care: a systematic review. Intensive Care Med 2001, 27:206.
88. Barrington K, Brion LP. Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants. Cochrane Database Syst Rev 2002;3:CD003213.
89. Lauschke A, Teichgraber UK, Frei U, Eckhardt KU "Low-dose" dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2004, 65:1416.
90. Kellum JA, Decker J Use of dopamine in acute failure: a meta-analysis. Crit Care Med 2001, 29(8):1526-1531.
91. Gouyon JB, Guignard JP Adenosine in the immature kidney. Dev Pharmacol Ther 1989, 13:113.
92. Huet F, Semama D, Grimaldi M, et al. Effects of theophylline on renal insufficiency in neonates with respiratory distress syndrome. Intensive Care Med 1995, 21:511.
93. Jenik AG, Ceriani Cernadas JM, Gorenstein A, et al. A randomized, double blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia. Pediatrics 2000, 105(4):e45.
94. Bakr AF Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia-a study in a developing country. Pediatr Nephrol 2005, 20:1249.
95. Bhat MA, Shah ZA, Makhdoomi MS, Mufti MH Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial. J Pediatr 2006, 149:e180-e184.
96. Eslami Z, Shajari A, Kheirandish M, et al. Theophylline for prevention of kidney dysfunction in neonates with severe asphyxia. Iran J Kidney Dis 2009, 3:222.
97. Cattarelli D, Spandrio M, Gasparoni A, et al. A randomized, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 2006, 91:F80.
98. Prévot A, Mosig D, Rijtema M, et al. Renal effects of adenosine A1-receptor blockade with 8-cyclopentyl-1, 3-dipropylxanthine in hypoxemic newborn rabbits. Pediatr Res 2003, 54:400.